Strategic Initiative

Slingshot members are tracking this corporate initiative:

AstraZeneca (AZN) Sells U.S Rights to Rhinocort Aqua OTC Nasal Spray for Allergic and Non-Allergic Rhinitis and Nasal Polyps to Cilag GmbH International (JNJ) for $330MM Cash

Source Link:: https://www.astrazeneca.com/media-centre/press-releases/2016/astrazeneca-enters-agreement-with-cilag-gmbh-international-to-divest-rights-to-rhinocort-aqua-outside-the-us-071020161.html

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies

Importance

High

Medium

Low

Impact on Stocks

JNJ

100%

Cilag GmbH International

100%

AZN

100%

SIGN ME UP
I want to vote! LOG ME IN
Now!

Slingshot Insights Explained

JOIN FOR FREE TODAY

Strategic Initiative Date

Announcement Date:

Oct 07, 2016

Projected Implementation:

Q4, 2016

Relevance Tracked Until:

Q2, 2017

Related Projects

Don’t see a project related to the strategic initiative you care about?

Related Keywords U.s Rights, Rhinocort Aqua Otc Nasal Spray, Allergic And Non-allergic Rhinitis, Nasal Polyps, Cash Deal